Compare Nutanix Inc (NTNX) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs uniQure N.V. Ordinary Shares — how do they compare? Nutanix Inc trades at $69.82 (market cap $18.90B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Nutanix Inc is far larger — about 13× uniQure N.V. Ordinary Shares's market cap, and Nutanix Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nutanix Inc for 17 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NTNX | QURE | |
|---|---|---|
Market Cap | $18.90B | $1.45B |
Volume | 3,504,387 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $74.63 | $70.59 |
52-Week Low | $34.41 | $9.03 |
Typical Hold Time | 17 Days | 0 Days |
Enterprise Value | $18.06B | $707.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutanix (NTNX) trades at $72.88, down 1.7% on the day but maintains strong technical momentum with bullish moving averages and recent earnings beats. The company reported robust Q4 2026 results exceeding expectations, with revenue growth to $2.9B and net profit margin expanding to 52.8%. Recent Gartner Magic Quadrant recognitions highlight competitive strength in virtualization and container management platforms.
Outlook remains positive with 62.5% analyst buy ratings and $76.11 consensus price target, though elevated P/S ratio and negative ROE warrant monitoring. Key risks include supply chain pressures and competitive threats in cloud infrastructure, while AI growth initiatives present long-term opportunity.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
